Principaux enjeux de la production de cellules hématopoí étiques à partir de cellules souches embryonnaires humaines

Translated title of the contribution: Hematopoietic cells production from human embryonic stem cells

Research output: Contribution to journalArticle

Abstract

Human embryonic stem cells (hESC) exhibit the remarkable property of being pluripotent: they theoretically can be differentiated in all cell types and have generated great hopes for regenerative medicine. Although hESCs were isolated only recently, our understanding of these cells has progressed very rapidly because of previous research on mouse ES cells. Clinical use of hESCs will require advances in the methods of isolation and culture in particular the elimination of components of animal origin. In addition, progress must be made to specifically direct differentiation toward useful cell types. Hematopoietic differentiation of hESC is now routinely obtained in numerous laboratories. Within hematopoiesis, erythropoiesis lineage seems to have the greatest potential for short-term clinical applications because of the relative simplicity of red blood cells and the fact that they do not express HLA antigens. However, hESC-derived erythrocytes obtained up to now exhibit, as revealed by morphological and globin analysis, developmentally immature phenotype similar to cells produced in the yolk sack or the early fetal liver that are probably not suitable for practical application. Clinical application will only become possible after a certain number of practical and fundamental issues are resolved.

Original languageFrench
Pages (from-to)153-164
Number of pages12
JournalHematologie
Volume13
Issue number3
DOIs
StatePublished - Jun 2007

Fingerprint

Erythrocytes
Regenerative Medicine
Globins
Erythropoiesis
Hematopoiesis
HLA Antigens
Human Embryonic Stem Cells
Phenotype
Liver
Research

Keywords

  • Erythrocyte
  • Hematopoietic cell
  • Human embryonic stem cell

ASJC Scopus subject areas

  • Hematology

Cite this

@article{ca4c3f8736f44938b76c6344e78090ba,
title = "Principaux enjeux de la production de cellules h{\'e}matopo{\'i} {\'e}tiques {\`a} partir de cellules souches embryonnaires humaines",
abstract = "Human embryonic stem cells (hESC) exhibit the remarkable property of being pluripotent: they theoretically can be differentiated in all cell types and have generated great hopes for regenerative medicine. Although hESCs were isolated only recently, our understanding of these cells has progressed very rapidly because of previous research on mouse ES cells. Clinical use of hESCs will require advances in the methods of isolation and culture in particular the elimination of components of animal origin. In addition, progress must be made to specifically direct differentiation toward useful cell types. Hematopoietic differentiation of hESC is now routinely obtained in numerous laboratories. Within hematopoiesis, erythropoiesis lineage seems to have the greatest potential for short-term clinical applications because of the relative simplicity of red blood cells and the fact that they do not express HLA antigens. However, hESC-derived erythrocytes obtained up to now exhibit, as revealed by morphological and globin analysis, developmentally immature phenotype similar to cells produced in the yolk sack or the early fetal liver that are probably not suitable for practical application. Clinical application will only become possible after a certain number of practical and fundamental issues are resolved.",
keywords = "Erythrocyte, Hematopoietic cell, Human embryonic stem cell",
author = "Olivier, {Emmanuel N.} and Bouhassira, {Eric E.}",
year = "2007",
month = "6",
doi = "10.1684/hma.2007.0153",
language = "French",
volume = "13",
pages = "153--164",
journal = "Hematologie",
issn = "1264-7527",
publisher = "John Libbey Eurotext",
number = "3",

}

TY - JOUR

T1 - Principaux enjeux de la production de cellules hématopoí étiques à partir de cellules souches embryonnaires humaines

AU - Olivier, Emmanuel N.

AU - Bouhassira, Eric E.

PY - 2007/6

Y1 - 2007/6

N2 - Human embryonic stem cells (hESC) exhibit the remarkable property of being pluripotent: they theoretically can be differentiated in all cell types and have generated great hopes for regenerative medicine. Although hESCs were isolated only recently, our understanding of these cells has progressed very rapidly because of previous research on mouse ES cells. Clinical use of hESCs will require advances in the methods of isolation and culture in particular the elimination of components of animal origin. In addition, progress must be made to specifically direct differentiation toward useful cell types. Hematopoietic differentiation of hESC is now routinely obtained in numerous laboratories. Within hematopoiesis, erythropoiesis lineage seems to have the greatest potential for short-term clinical applications because of the relative simplicity of red blood cells and the fact that they do not express HLA antigens. However, hESC-derived erythrocytes obtained up to now exhibit, as revealed by morphological and globin analysis, developmentally immature phenotype similar to cells produced in the yolk sack or the early fetal liver that are probably not suitable for practical application. Clinical application will only become possible after a certain number of practical and fundamental issues are resolved.

AB - Human embryonic stem cells (hESC) exhibit the remarkable property of being pluripotent: they theoretically can be differentiated in all cell types and have generated great hopes for regenerative medicine. Although hESCs were isolated only recently, our understanding of these cells has progressed very rapidly because of previous research on mouse ES cells. Clinical use of hESCs will require advances in the methods of isolation and culture in particular the elimination of components of animal origin. In addition, progress must be made to specifically direct differentiation toward useful cell types. Hematopoietic differentiation of hESC is now routinely obtained in numerous laboratories. Within hematopoiesis, erythropoiesis lineage seems to have the greatest potential for short-term clinical applications because of the relative simplicity of red blood cells and the fact that they do not express HLA antigens. However, hESC-derived erythrocytes obtained up to now exhibit, as revealed by morphological and globin analysis, developmentally immature phenotype similar to cells produced in the yolk sack or the early fetal liver that are probably not suitable for practical application. Clinical application will only become possible after a certain number of practical and fundamental issues are resolved.

KW - Erythrocyte

KW - Hematopoietic cell

KW - Human embryonic stem cell

UR - http://www.scopus.com/inward/record.url?scp=34547651365&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34547651365&partnerID=8YFLogxK

U2 - 10.1684/hma.2007.0153

DO - 10.1684/hma.2007.0153

M3 - Article

VL - 13

SP - 153

EP - 164

JO - Hematologie

JF - Hematologie

SN - 1264-7527

IS - 3

ER -